Wintest
6721
D. Western Therapeutics Institute
4576
Ridge-i
5572
Hamee
3134
River Eletec
6666
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 2.05%24.09B | 13.61%118.94B | 4.51%39.49B | 88.00%25.27B | -17.58%30.58B | 44.19%23.61B | -15.30%104.7B | -19.09%37.78B | -14.07%13.44B | -16.23%37.1B |
Net profit before non-cash adjustment | -3.89%34.21B | 12.05%111.48B | -2.86%25.61B | 6.78%20.93B | -10.02%29.35B | 70.20%35.59B | 42.42%99.49B | -18.34%26.37B | -22.10%19.6B | 596.26%32.62B |
Total adjustment of non-cash items | 74.09%-1.12B | 12.42%39.71B | 164.67%14.95B | -14.09%17.02B | 14.13%12.05B | -524.53%-4.3B | -48.18%35.33B | -67.02%5.65B | 57.70%19.81B | -73.40%10.56B |
-Depreciation and amortization | 4.62%13.08B | 0.51%52.67B | -7.82%13.76B | 6.07%13.4B | 1.84%13.01B | 3.58%12.5B | 7.60%52.41B | 22.89%14.93B | 5.23%12.64B | 3.92%12.77B |
-Reversal of impairment losses recognized in profit and loss | ---- | 782.05%4.13B | ---- | ---- | ---- | ---- | -99.09%468M | ---- | ---- | ---- |
-Share of associates | 162.98%228M | 62.60%-843M | 29.00%-847M | 171.83%386M | 98.29%-20M | -964.71%-362M | -1,987.04%-2.25B | -2,156.90%-1.19B | -89.71%142M | 8.46%-1.17B |
-Disposal profit | 42.86%-7.66B | -520.36%-9.69B | 67.96%3.37B | 604.29%353M | 107.50%6M | -3,080.00%-13.41B | 109.46%2.3B | 305.67%2B | 97.95%-70M | 99.48%-80M |
-Other non-cash items | -123.00%-6.76B | 62.72%-6.56B | 48.27%-5.47B | -59.50%2.88B | 2.29%-940M | 76.99%-3.03B | -132.75%-17.6B | -452.02%-10.56B | 184.04%7.1B | 83.42%-962M |
Changes in working capital | -17.20%-9B | -7.04%-32.25B | -118.51%-1.07B | 51.17%-12.68B | -78.06%-10.82B | -99.51%-7.68B | -108.80%-30.13B | 312.10%5.77B | -17.61%-25.96B | -154.46%-6.08B |
-Change in receivables | -10.64%14.85B | -634.00%-11.36B | -135.36%-9.58B | 81.79%-737M | -124.29%-17.65B | 15.07%16.62B | 78.78%-1.55B | -10.95%-4.07B | 75.26%-4.05B | -171.75%-7.87B |
-Change in inventory | 31.54%-8.03B | 93.63%-2.34B | 104.88%6.51B | 62.99%-6.6B | 1,454.57%9.48B | 45.10%-11.73B | -118.11%-36.72B | -31.03%3.18B | -48.54%-17.84B | -113.63%-700M |
-Change in prepaid assets | -54.85%3.13B | -135.34%-2.66B | ---- | ---- | ---- | -13.01%6.94B | 1,073.06%7.51B | ---- | ---- | ---- |
-Change in payables | 28.62%-15.57B | -249.20%-17.86B | 245.80%2.19B | -36.55%1.61B | -96.00%156M | -117.07%-21.81B | -138.88%-5.11B | -120.80%-1.5B | -68.15%2.53B | -60.43%3.9B |
-Provision for loans, leases and other losses | -5.13%-6.41B | ---- | ---- | ---- | ---- | 12.48%-6.1B | ---- | ---- | ---- | ---- |
-Changes in other current assets | -64.02%3.02B | -65.88%1.96B | 28.78%-6.28B | -36.53%1.81B | -394.22%-1.97B | -30.64%8.39B | 313.82%5.74B | 48.82%-8.82B | -47.83%2.86B | 85.41%-398M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 3.03%-352M | -48.17%-1.29B | -17.75%-325M | -23.16%-234M | -82.27%-370M | -78.82%-363M | -10.38%-872M | -24.89%-276M | 4.04%-190M | -50.37%-203M |
Interest received (cash flow from operating activities) | -14.36%2.28B | 11.23%6.25B | 141.23%1.1B | -7.04%938M | -1.59%1.54B | 3.21%2.67B | 7.01%5.62B | 153.33%456M | 13.37%1.01B | 1.49%1.57B |
Tax refund paid | -42.76%-21.17B | 54.44%-17.26B | 427.53%1.62B | 32.43%-10.55B | 823.61%6.5B | 29.01%-14.83B | -64.45%-37.9B | 93.29%-494M | -128.78%-15.62B | -10.86%-898M |
Other operating cash inflow (outflow) | 0.00%1M | 0 | 0 | 0 | 50.00%-1M | 0.00%1M | -1M | -200.00%-1M | 200.00%1M | -2M |
Operating cash flow | -56.16%4.86B | 49.05%106.63B | 11.78%41.88B | 1,235.42%15.42B | 1.82%38.25B | 620.27%11.09B | -31.88%71.54B | -4.64%37.47B | -114.29%-1.36B | -16.32%37.57B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 1.86%-11.24B | -4.91%-45.19B | -13.33%-11.63B | 28.69%-9.63B | -6.41%-12.47B | -51.07%-11.45B | -21.16%-43.07B | 6.63%-10.26B | -57.81%-13.51B | -49.41%-11.72B |
Net intangibles purchase and sale | -47.49%-2.26B | -35.10%-14.38B | 24.27%-3.28B | -190.53%-5.83B | -123.34%-3.73B | 41.66%-1.54B | -39.75%-10.64B | -94.87%-4.33B | -10.46%-2.01B | 22.82%-1.67B |
Net business purchase and sale | ---- | 964.33%16.26B | --0 | 59.42%-476M | ---- | ---- | 25,566.67%1.53B | --183M | ---1.17B | ---- |
Net investment product transactions | -65.75%7.27B | 449.75%25.89B | 78.78%-754M | 519.20%6.59B | 42.15%-1.16B | 7,985.87%21.21B | -116.11%-7.4B | -134.74%-3.55B | -121.95%-1.57B | -107.44%-2.01B |
Repayment of advance payments to other parties and cash income from loans | 166.53%161M | -3,920.83%-917M | 96.64%-5M | 2,214.29%148M | ---818M | -234.44%-242M | 366.67%24M | -547.83%-149M | 75.86%-7M | --0 |
Net changes in other investments | 205.08%62M | -244.70%-191M | -103.25%-250M | -1,038.10%-197M | 129.93%315M | -160.82%-59M | 259.04%132M | 25.90%-123M | -80.37%21M | 203.79%137M |
Investing cash flow | -175.94%-6.02B | 68.85%-18.52B | 12.71%-15.92B | 48.53%-9.39B | 91.14%-1.13B | 177.64%7.92B | -2,306.01%-59.43B | -22.27%-18.24B | -482.91%-18.25B | -175.44%-12.74B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -582.58%-7.88B | 28.32%-2.13B | 94.37%-657M | -97.13%276M | 37.98%-596M | -3,706.25%-1.15B | 81.87%-2.97B | -6,244.57%-11.67B | 187.06%9.63B | 81.93%-961M |
Net common stock issuance | -13.88%-8.92B | 41.00%-16.17B | 99.91%-2M | 25.06%-8.34B | 0.00%-1M | 44.34%-7.83B | -188.56%-27.41B | -221,100.00%-2.21B | -188.76%-11.13B | 0.00%-1M |
Increase or decrease of lease financing | -0.35%-1.42B | -0.16%-5.7B | 4.36%-1.38B | 0.91%-1.42B | -8.80%-1.48B | 2.42%-1.41B | -5.25%-5.69B | -8.24%-1.45B | -1.41%-1.44B | -1.56%-1.36B |
Cash dividends paid | -27.61%-16.48B | -16.85%-27.83B | 6.67%16M | -17.71%-14.94B | 237.50%11M | -16.05%-12.92B | -10.61%-23.82B | 1,400.00%15M | -18.24%-12.69B | -214.29%-8M |
Cash dividends for minorities | -4.08%-102M | 1.56%-1.26B | 36.59%-52M | ---353M | 26.78%-760M | 39.88%-98M | 21.91%-1.28B | -24.24%-82M | --0 | 21.30%-1.04B |
Net other fund-raising expenses | 75.64%137M | 104.33%75M | --0 | -200.00%-3M | --0 | 104.45%78M | -587.30%-1.73B | 50.00%-3M | 99.55%-1M | 360.00%23M |
Financing cash flow | -48.54%-34.66B | 15.71%-53.02B | 86.51%-2.08B | -58.59%-24.78B | 15.50%-2.83B | 18.21%-23.34B | -14.94%-62.91B | -868.01%-15.4B | 43.05%-15.63B | 57.98%-3.35B |
Net cash flow | ||||||||||
Beginning cash position | 48.31%126.37B | -36.29%85.21B | 24.42%100.08B | 1.27%119.84B | -12.22%84.4B | -36.29%85.21B | 74.48%133.74B | -25.45%80.43B | -7.24%118.34B | 29.59%96.15B |
Current changes in cash | -728.16%-35.82B | 169.09%35.09B | 523.60%23.88B | 46.77%-18.75B | 59.68%34.29B | 89.42%-4.33B | -195.86%-50.79B | -83.19%3.83B | -67.28%-35.23B | -60.10%21.47B |
Effect of exchange rate changes | -16.51%2.93B | 167.82%6.06B | 154.98%2.41B | 62.19%-1.01B | 60.70%1.15B | 7.20%3.51B | -44.34%2.26B | -69.24%944M | -300.15%-2.67B | 263.24%715M |
Cash adjustments other than cash changes | 1,400.00%60M | 900.00%8M | ---1M | --0 | --5M | 500.00%4M | -102.63%-1M | --0 | --0 | --0 |
End cash Position | 10.83%93.54B | 48.31%126.37B | 48.31%126.37B | 24.42%100.08B | 1.27%119.84B | -12.22%84.4B | -36.29%85.21B | -36.29%85.21B | -25.45%80.43B | -7.24%118.34B |
Free cash flow | -322.08%-8.93B | 205.08%46.18B | 17.25%26.65B | 98.89%-206M | -7.27%21.85B | 83.28%-2.12B | -74.94%15.14B | -12.60%22.73B | -1,165.53%-18.5B | -30.97%23.56B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |